ArticleCell death & disease2021

LncRNA PCBP1-AS1-mediated AR/AR-V7 deubiquitination enhances prostate cancer enzalutamide resistance.

Boya Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.